Incyte Corp
Change company Symbol lookup
Select an option...
INCY Incyte Corp
ATEC Alphatec Holdings Inc
AEHL Antelope Enterprise Holdings Ltd
AULT-D Ault Alliance Inc
TWI Titan International Inc
MMV MultiMetaVerse Holdings Limited
TMUS T-Mobile US Inc
ADBE Adobe Inc
YJ Yunji Inc
CGEN Compugen Ltd
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. The Company also conducts commercial and clinical development operations from its European headquarters in Morges, Switzerland, and Japanese office in Tokyo and Canadian headquarters in Montreal. It operates in two therapeutic areas, One therapeutic area is Hematology/Oncology, which is comprised of Myeloproliferative Neoplasms and Graft-Versus-Host Disease, as well as solid tumors and hematologic malignancies. The other therapeutic area is Inflammation and Autoimmunity, which includes its Dermatology commercial franchise. Its hematology and oncology franchise are comprised of four products, which are JAKAFI (ruxolitinib), MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), PEMAZYRE (pemigatinib) and ICLUSIG (ponatinib), as well as other clinical development programs. Its Dermatology commercial franchise is comprised of OPZELURA (ruxolitinib) cream.

Closing Price
$62.54
Day's Change
1.03 (1.67%)
Bid
--
Ask
--
B/A Size
--
Day's High
62.60
Day's Low
61.42
Volume
(Average)
Volume:
1,760,372

10-day average volume:
1,852,967
1,760,372
  • Prev Close
    61.51
  • Today's Open
    61.50
  • Day's Range
    61.42-62.60
  • Avg Vol (10-day)
    1.9M
  • Last (time)
    4:00p ET 06/02/23
  • Last (size)
    101
  • 52-Wk Range
    60.71 - 86.29
    LowHigh
  • (01/26/23 - 06/01/23)
    3.01%
  • 25.2%
  • Market Cap
    14.0B
  • Shares Outstanding
    223.1M
  • 1.45
  • 43.20x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.7
  • 98.65
  • (% of float 05/15/23)
    3.19

Latest News

June 02, 2023
5:15 pm ET
MarketWatch
June 01, 2023
5:02 pm ET
MarketWatch
May 31, 2023
5:02 pm ET
MarketWatch
May 30, 2023
5:02 pm ET
MarketWatch
May 26, 2023
5:02 pm ET
MarketWatch
May 25, 2023
5:03 pm ET
MarketWatch
5:01 pm ET
BusinessWire
May 24, 2023
5:02 pm ET
MarketWatch
May 23, 2023
5:02 pm ET
MarketWatch
8:00 am ET
BusinessWire
May 22, 2023
5:02 pm ET
MarketWatch
May 19, 2023
5:01 pm ET
MarketWatch
May 18, 2023
5:02 pm ET
MarketWatch
May 17, 2023
5:02 pm ET
MarketWatch
May 16, 2023
5:02 pm ET
MarketWatch
May 15, 2023
5:02 pm ET
MarketWatch
May 12, 2023
5:02 pm ET
MarketWatch
May 11, 2023
5:03 pm ET
MarketWatch
May 10, 2023
5:02 pm ET
MarketWatch
May 09, 2023
5:03 pm ET
MarketWatch
May 08, 2023
5:03 pm ET
MarketWatch
8:30 am ET
BusinessWire
May 05, 2023
5:03 pm ET
MarketWatch
May 04, 2023
5:02 pm ET
MarketWatch
11:53 am ET
MarketWatch
May 03, 2023
5:03 pm ET
MarketWatch
May 02, 2023
5:02 pm ET
MarketWatch
7:00 am ET
BusinessWire
May 01, 2023
5:02 pm ET
MarketWatch
3:00 pm ET
BusinessWire
April 28, 2023
5:01 pm ET
MarketWatch
April 26, 2023
5:02 pm ET
MarketWatch
April 25, 2023
5:02 pm ET
MarketWatch
April 24, 2023
5:02 pm ET
MarketWatch
2:19 pm ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.